Javascript must be enabled to continue!
CD28 Utilizes Vav-1 to Enhance TCR-Proximal Signaling and NF-AT Activation
View through CrossRef
Abstract
The mechanism through which CD28 costimulation potentiates TCR-driven gene expression is still not clearly defined. Vav-1, an exchange factor for Rho GTPases thought to regulate, mainly through Rac-1, various signaling components leading to cytokine gene expression, is tyrosine phosphorylated upon CD28 engagement. Here, we provide evidence for a key role of Vav-1 in CD28-mediated signaling. Overexpression of Vav-1 in Jurkat cells in combination with CD28 ligation strongly reduced the concentration of staphylococcus enterotoxin E/MHC required for TCR-induced NF-AT activation. Surprisingly, upon Vav-1 overexpression CD28 ligation sufficed to activate NF-AT in the absence of TCR engagement. This effect was not mediated by overexpression of ZAP-70 nor of SLP-76 but necessitated the intracellular tail of CD28, the intactness of the TCR-proximal signaling cascade, the Src-homology domain 2 (SH2) domain of Vav-1, and SLP-76 phosphorylation, an event which was favored by Vav-1 itself. Cells overexpressing Vav-1 formed lamellipodia and microspikes reminiscent of Rac-1 and Cdc42 activation, respectively, for which the SH2 domain of Vav-1 was dispensable. Together, these data suggest that CD28 engagement activates Vav-1 to boost TCR signals through a synergistic cooperation between Vav-1 and SLP-76 and probably via cortical actin changes to facilitate the organization of a signaling zone.
Oxford University Press (OUP)
Title: CD28 Utilizes Vav-1 to Enhance TCR-Proximal Signaling and NF-AT Activation
Description:
Abstract
The mechanism through which CD28 costimulation potentiates TCR-driven gene expression is still not clearly defined.
Vav-1, an exchange factor for Rho GTPases thought to regulate, mainly through Rac-1, various signaling components leading to cytokine gene expression, is tyrosine phosphorylated upon CD28 engagement.
Here, we provide evidence for a key role of Vav-1 in CD28-mediated signaling.
Overexpression of Vav-1 in Jurkat cells in combination with CD28 ligation strongly reduced the concentration of staphylococcus enterotoxin E/MHC required for TCR-induced NF-AT activation.
Surprisingly, upon Vav-1 overexpression CD28 ligation sufficed to activate NF-AT in the absence of TCR engagement.
This effect was not mediated by overexpression of ZAP-70 nor of SLP-76 but necessitated the intracellular tail of CD28, the intactness of the TCR-proximal signaling cascade, the Src-homology domain 2 (SH2) domain of Vav-1, and SLP-76 phosphorylation, an event which was favored by Vav-1 itself.
Cells overexpressing Vav-1 formed lamellipodia and microspikes reminiscent of Rac-1 and Cdc42 activation, respectively, for which the SH2 domain of Vav-1 was dispensable.
Together, these data suggest that CD28 engagement activates Vav-1 to boost TCR signals through a synergistic cooperation between Vav-1 and SLP-76 and probably via cortical actin changes to facilitate the organization of a signaling zone.
Related Results
Stimulation of Anti-Tumor Immunity Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28.
Stimulation of Anti-Tumor Immunity Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28.
Abstract
Dendritic Cells (DCs) are potent antigen presenting cells that prominently express costimulatory molecules and are uniquely capable of stimulating primary i...
Imbalance between CD8
+
CD28
+
and CD8
+
CD28
–
T-cell subsets and its clinical significance in
Imbalance between CD8
+
CD28
+
and CD8
+
CD28
–
T-cell subsets and its clinical significance in
Objective
The aim of this study was to evaluate the changes in CD8
+
CD28
...
High-affinity PD-1-CD28 switch receptor enhances sustained antitumor activity of CAR-T cells in both lymphoma and ewing sarcoma.
High-affinity PD-1-CD28 switch receptor enhances sustained antitumor activity of CAR-T cells in both lymphoma and ewing sarcoma.
Abstract
Background: Although CAR-T cell therapy has revolutionized the treatment of hematologic malignancies, durable r...
Clinicopathological significance of CD28 overexpression in adult T‐cell leukemia/lymphoma
Clinicopathological significance of CD28 overexpression in adult T‐cell leukemia/lymphoma
AbstractCD28, one of the costimulatory molecules, has a pivotal role in T‐cell activation, and its expression is strictly regulated in normal T cells. Gain‐of‐function genetic alte...
Oligoclonal Expansion of Effector Memory CD8+CD57+ T Cells May Sustain Bone Marrow Destruction in Aplastic Anemia
Oligoclonal Expansion of Effector Memory CD8+CD57+ T Cells May Sustain Bone Marrow Destruction in Aplastic Anemia
Abstract
The character of oligoclonal expansion of CD8+CD28- lymphocytes in aplastic anemia (AA), described by Risitano et al. (Blood, 2002 and Lancet, 2004), strong...
Modelling the T-cell repertoires of circulating T-cells and its application in cardiovascular diseases
Modelling the T-cell repertoires of circulating T-cells and its application in cardiovascular diseases
Modélisation du répertoire des lymphocytes T circulants et son application dans les maladies cardiovasculaires
Les maladies cardio-vasculaires MCV représentent la p...
Fine Tuning Bispecific Activity in CLL: Harmonizing a CD19/20-T Cell Bispecific with a CD28 or 4-1BBL Costimulatory Bispecific
Fine Tuning Bispecific Activity in CLL: Harmonizing a CD19/20-T Cell Bispecific with a CD28 or 4-1BBL Costimulatory Bispecific
Introduction:
T cell bispecific antibodies (TCBs), such as blinatumomab, mosunetuzumab or glofitamab, redirect T cells toward cancer cells and rely on endogenous T c...
Distinct CD28 signaling requirements determine the alternative fates of thymic agonist selection
Distinct CD28 signaling requirements determine the alternative fates of thymic agonist selection
Abstract
During thymic T cell development, T cells strongly reactive to self-Ag are eliminated from the conventional T cell repertoire by clonal deletion. Alternativ...

